Home » Newsletters » BioWorld Science

BioWorld Science

April 8, 2010

View Archived Issues

Swiss scientists describe novel anticancer agents

Sekmed discloses new vaccine adjuvants

Galapagos identifies novel androgen receptor ligands

SPARC staining predicts survival in rituximab-treated patients with ABC-type DLBCL

Two-year data reported on deferasirox in beta-thalassemia patients with cardiac siderosis

Quinapril and lipoic acid show benefit in metabolic syndrome

Preclinical data disclosed on discovery of novel CCK receptor antagonist JNJ-26273364

Amgen identifies novel CXCR3 antagonists for inflammatory conditions

Preclinical studies show involvement of galectin-1 in healing after acute myocardial infarction

Merck & Co. discloses new glucagon receptor antagonists

Bristol-Myers Squibb discovers new NS5B inhibitors

FDA grants fast track designation to Genta's tesetaxel for advanced gastric cancer

Lundbeck advances new agent Lu-AE-04621 to phase I for Parkinson's disease

FDA approves TachoSil surgical patch as adjunct to hemostasis in cardiovascular surgery

Allergan and Serenity Pharmaceuticals to collaborate on development Ser-120 for nocturia

Davunetide receives FDA fast track status for progressive supranuclear palsy

Bellus Health begins phase I trial of NRM-8499 for Alzheimer's disease

Living Cell Technologies' phase I/IIa Diabecell trial in type 1 diabetes meets endpoints

Recordati signs marketing agreement with Esteve for pitavastatin

Halozyme Therapeutics strengthens commercial supply agreements for rHuPH20

Multiple Myeloma Research Consortium initiates phase Ib/II Treanda trial in multiple myeloma

NeurogesX launches capsaicin patch for postherpetic neuralgia

Mologen receives funds to develop MIDGE-based DNA vaccine for hepatitis B

Phase II trial of ranibizumab in diabetic macular edema commences enrollment

MicuRx, Cumencor and Pfizer partner to develop antibiotics for multidrug-resistant tuberculosis

RXi and TransDerm form dermatology research collaboration

Popular Stories

University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Beijing Innocare Pharma Tech discloses new GSPT1 degradation inducers
BioWorld Science
Beijing Innocare Pharma Tech Co. Ltd. has synthesized new antibody-drug conjugates comprising antibody or antigen-binding fragment covalently linked to eukaryotic...